Skip to main content
. 2023 Jan 22;11(2):311. doi: 10.3390/biomedicines11020311

Figure 7.

Figure 7

Survival in relation to PD-L1 expression in patients from the Cancer Genome Atlas (TCGA) PanCancer Atlas. Overall (a) and progression-free (b) survival in 142 patients with glioblastoma (IDH1/2 wild type), according to PD-L1 expression levels (below to above median).